The largest database of trusted experimental protocols

Dr274 vector

Manufactured by Addgene

The DR274 vector is a plasmid used for the expression of guide RNA (gRNA) in CRISPR-Cas9 gene editing experiments. The vector contains a human U6 promoter to drive the expression of the gRNA sequence, which can be customized by the user. The vector also includes a pUC origin of replication and an ampicillin resistance marker for selection in bacterial cultures.

Automatically generated - may contain errors

3 protocols using dr274 vector

1

CRISPR sgRNA Design and Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The online tool CCTop (Stemmer et al., 2015 (link)) was used to design sgRNAs. sgRNAs were generated as previously described by Hwang et al., 2013 (link). Oligonucleotides were annealed and ligated into DR274 vector (Addgene), which was previously linearized using BsaI-HF (New England Biolabs). Template for in vivo transcription of sgRNA was amplified by PCR. In vivo transcription was performed using the HiScribe T7 Quick High Yield RNA Synthesis Kit (New England Biolabs) and RNA was purified using the RNeasy Mini kit (Qiagen). Quantity and quality of sgRNA were analyzed using a NanoDrop and agarose gel electrophoresis. sgRNA cleaving activity was confirmed by an in vivo assay.
+ Open protocol
+ Expand
2

Generation of CRISPR/Cas9-mediated Zebrafish Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cas9 mRNA was in vitro transcribed from pXT7 using the mMessage mMachine kit (ThermoFisher) as previously described with some modifications [42 (link)]. CRISPR/Cas9 target site in exon 3 of nrg1 were identified using ZiFit software [43 (link)] and zebrafish genomic sequence, build GRCz9 [44 (link)]. Single stranded oligonucleotides corresponding to the targeting sequence were annealed and cloned into the DR274 vector (Addgene) [45 (link)], then transcribed in vitro with T7 MaxiScript kit (ThermoFisher). Cas9 plasmid was generously provided by Dr. Jing-Wei Xiong. Embryos were injected at the one cell stage with 1–2 nl of a mixture containing 1200 ng Cas9, 50–75 ng gRNA, 10 mM MgCl, and 0.01% phenol red. gRNA targeting efficiency was determined by High Resolution Melt Analysis (HRMA) [46 (link)] as described below using primers flanking the target site. F1 offspring from F0 founders that carry favorable mutations, determined by DNA sequencing of the target site, were raised to adulthood. Heterozygous F1 fish were interbred to produce homozygous wild type, homozygous mutant, and heterozygous mutant offspring.
+ Open protocol
+ Expand
3

CRISPR-Cas9 Gene Disruption in Xenopus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tpm1 sgRNA sequences were designed by the online tool ZiFiT targeter (http://zifit.partners.org/ZiFiT/). To assemble sgRNA, two oligonucleotides were annealed and linked to the linearized DR274 vector (Addgene #42250). After Dra1 digestion, the sgRNA-DR274 vector was used as template for in vitro transcription (MAXIscript T7 transcription kit, ThermoFisher). Tpm1 sgRNA was purified and co-injected with Cas9 protein (PNA BIO Inc) into the X. tropicalis embryos at the 1 cell stage. To assess gene disruption efficiency, ten of the injected or uninjected embryos were harvested at stage 32 for western blot or T7E1 assay as previously described.57 (link) The CRISPR-Cas9 target region was also amplified from the extracted genomic DNA and analyzed by sequencing. The CRISPR-Cas9 injected embryos were observed on stage 42 under microscope for heart rate and edema. The Cas9 injected embryos were used as control. All embryos were harvested for further histopathological analyses in a similar fashion to the MO experiments. Assessment for ASD was carried out using ECM imaging as described below.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!